Kimia Therapeutics develops a drug discovery platform that combines high-throughput precision chemistry, genome editing, and machine learning to create a detailed chemical atlas of druggable targets in oncology, immunology, and inflammation. This technology enables the rapid identification of therapeutic compounds and the generation of extensive datasets that inform drug design and optimization.
Funding
$57.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
DCTCFounders
Product
Problem
Traditional drug discovery processes are slow and inefficient, often struggling to identify novel therapeutic compounds and druggable targets, particularly in complex diseases like cancer, immunological disorders, and inflammation. The vast chemical space and intricate biological interactions make it challenging to pinpoint effective drug candidates and optimize their design.
Solution
Kimia Therapeutics offers a drug discovery platform, ATLAS, that accelerates the identification of therapeutic compounds by creating a detailed chemical atlas of druggable space. ATLAS integrates active learning, automated synthesis, and high-throughput screening with machine learning to map the relationship between chemical structure and protein function at single-atom resolution. This approach enables the generation of billions of target-directed compounds on demand and the creation of extensive datasets, including proteomic and gene editing information, to ensure appropriate engagement of intracellular pathways. Machine learning algorithms interpret these datasets to reveal trends that guide chemical design and lead optimization, fundamentally transforming the landscape of drug discovery.
Target Audience
Kimia's primary customers are pharmaceutical companies and research institutions focused on discovering novel therapeutics for oncology, immunology, and inflammation.
Features
- AcTive® Learning technology to accelerate drug discovery
- Automated synthesis and high-throughput screening for rapid compound generation
- Machine learning algorithms to identify therapeutic targets and corresponding drug molecules
- Target-directed precision chemistry to access billions of compounds on demand
- Proteomic and gene editing data integration to ensure appropriate engagement of intracellular pathways
- Chemical atlas of druggable space mapping chemical structure to protein function at single-atom resolution